Christine Ring Nurix Therapeutics, Inc. (NRIX) insider trading activity

Christine Ring is Chief Legal Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 37,318 shares of NRIX, which is worth approximately $374,672. The most recent transaction as insider was on Oct 31, 2022, when has been sold 699 shares (Common Stock) at a price of $12.88 per share, resulting in proceeds of $9,003. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.3K

14.69% 3M change

88.11% 12M change

Total Value Held $374,672

Christine Ring Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2022	SELL Open market or private sale	$9,003 $12.88 p/Share	699 Reduced 10.15%	6,185 Common Stock
Oct 30 2022	BUY Exercise of conversion of derivative security	-	1,924 Added 21.84%	6,884 Common Stock
Aug 01 2022	SELL Open market or private sale	$11,157 $15.67 p/Share	712 Reduced 13.37%	4,615 Common Stock
Jul 30 2022	BUY Exercise of conversion of derivative security	-	1,924 Added 26.53%	5,327 Common Stock
May 02 2022	SELL Open market or private sale	$7,755 $11.75 p/Share	660 Reduced 16.24%	3,403 Common Stock
Apr 30 2022	BUY Exercise of conversion of derivative security	-	1,924 Added 32.14%	4,063 Common Stock
Jan 10 2022	SELL Open market or private sale	$32,568 $27.14 p/Share	1,200 Reduced 48.27%	1,286 Common Stock
Jan 10 2022	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 32.56%	2,486 Common Stock
Dec 10 2021	SELL Open market or private sale	$34,848 $29.04 p/Share	1,200 Reduced 48.27%	1,286 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 32.56%	2,486 Common Stock
Nov 10 2021	SELL Open market or private sale	$38,856 $32.38 p/Share	1,200 Reduced 48.27%	1,286 Common Stock
Nov 10 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 32.56%	2,486 Common Stock
Oct 27 2021	SELL Open market or private sale	$28,200 $35.25 p/Share	800 Reduced 38.35%	1,286 Common Stock
Oct 27 2021	BUY Exercise of conversion of derivative security	$1,488 $1.86 p/Share	800 Added 27.72%	2,086 Common Stock
Oct 11 2021	SELL Open market or private sale	$32,832 $27.36 p/Share	1,200 Reduced 48.27%	1,286 Common Stock
Oct 11 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 32.56%	2,486 Common Stock
Sep 10 2021	SELL Open market or private sale	$71,760 $35.88 p/Share	2,000 Reduced 60.86%	1,286 Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$3,720 $1.86 p/Share	2,000 Added 37.84%	3,286 Common Stock
Sep 07 2021	SELL Open market or private sale	$112,800 $35.25 p/Share	3,200 Reduced 71.33%	1,286 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$5,952 $1.86 p/Share	3,200 Added 41.63%	4,486 Common Stock
Aug 10 2021	SELL Open market or private sale	$35,844 $29.87 p/Share	1,200 Reduced 59.85%	805 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 37.44%	2,005 Common Stock
Jul 20 2021	SELL Open market or private sale	$32,400 $27.0 p/Share	1,200 Reduced 59.85%	805 Common Stock
Jul 20 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 37.44%	2,005 Common Stock
Jun 10 2021	SELL Open market or private sale	$35,820 $29.85 p/Share	1,200 Reduced 59.85%	805 Common Stock

Christine Ring

Chief Legal Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Value

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX

Account